Details

Autor(en) / Beteiligte

• Morel, D. R
• Skoskiewicz, M
• Robinson, D. R
• Bloch, K. J
• Hoaglin, D. C
• Zapol, W. M

Titel

Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep

Ist Teil von

• American journal of physiology. Heart and circulatory physiology, 1991-09, Vol.261 (3), p.H782-H792

Ort / Verlag

United States

Erscheinungsjahr

1991

Quelle

MEDLINE

Beschreibungen/Notizen

• D. R. Morel, M. Skoskiewicz, D. R. Robinson, K. J. Bloch, D. C. Hoaglin and W. M. Zapol Department of Anesthesia, Harvard Medical School, Massachusetts General Hospital, Boston 02114. We investigated the roles of eicosanoid mediators in acute systemic anaphylaxis in anesthetized sheep. Sheep were sensitized with dinitrophenylated Ascaris suum extract and were challenged with an intravenous injection of dinitrophenylated bovine serum albumin. During anaphylaxis, cyclooxygenase inhibitors eliminated the elevation of arterial plasma levels of thromboxane B2 and 6-ketoprostaglandin F 1 alpha but markedly elevated the levels of leukotriene E4 in lung lymph without significantly eliminating elevation of plasma levels of histamine. Most of the measured physiological abnormalities accompanying anaphylaxis were aggravated by cyclooxygenase blockade. Enhancement of this anaphylactic mediator response was associated with an accentuated and prolonged increase of airway pressure (P less than 0.05, compared with sensitized, antigen-challenged but otherwise untreated sheep), a more intense hypoxemia (P less than 0.0001), and leukopenia (P less than 0.001), changes that were largely eliminated by pretreating with the sulfidopeptide leukotriene (SPLT) antagonist FPL 55712, suggesting that the SPLTs were important mediators of these responses. In contrast, the prolonged, but less severe, systemic vascular collapse and the reduced pulmonary hypertension induced by cyclooxygenase inhibitors were not influenced by the SPLT antagonist. These results demonstrate that in sheep cyclooxygenase metabolites are mainly involved in the acute, but transient, systemic and pulmonary vascular response of systemic anaphylaxis, whereas SPLTs are primarily implicated in the airway and secondary cardiovascular response. SPLT may act either directly or by potentiating the release of and reactivity to histamine and other mediators. Our data therefore suggest that a combination of cyclooxygenase and lipoxygenase inhibition will be necessary to more effectively protect against the consequences of an anaphylactic reaction.